233.95 -4.15 (-1.74%)

Near 52W High

2.8M NSE+BSE Volume

NSEJun 17, 2021 03:31 PM



Fortis Healthcare Ltd.    
17 Jun 2021, 09:11PM
233.95
-1.74%
Sputnik V COVID-19 vaccine to be available at 2 Fortis Hospitals from June 19
Sputnik V COVID-19 vaccine to be available at 2 Fortis Hospitals from June 19
Business Today
The two hospitals that are participating in the pilot roll-out of Sputnik V are Fortis Memorial Research Institute, Gurugram and Fortis Hospital, Mohali
Fortis Healthcare Ltd.    
10 Jun 2021
233.95
-1.74%
HDFC Securities sees 15% upside in Fortis Healthcare despite cap on vaccination charge, here's why
HDFC Securities sees 15% upside in Fortis Healthcare despite cap on vaccination charge, here's why
Moneycontrol
The brokerage firm has a buy on the stock on dips around Rs 199-200 with a target price of Rs 271, an upside of 15 percent from the current level.
Fortis Healthcare Ltd. has gained 47.84% in the last 6 Months
Fortis Healthcare Ltd.    
07 Jun 2021
233.95
-1.74%
Private hospitals divided on Rs 150 cap on COVID-19 vaccine administration charges
Private hospitals divided on Rs 150 cap on COVID-19 vaccine administration charges
Moneycontrol
Corporate hospital chains such as Apollo, Max Healthcare, Fortis Healthcare, Narayana Health and Manipal Hospitals have shown huge interest in offering COVID-19 vaccination.
Fortis Healthcare Ltd. is trading above all available SMAs
Fortis Healthcare Ltd.    
30 May 2021
233.95
-1.74%
Fortis Healthcare reports Rs 62 cr net profit in Q4 of FY21
Fortis Healthcare reports Rs 62 cr net profit in Q4 of FY21
Business Today
Consolidated revenue from operations of the company stood at Rs 1,252.44 crore for the quarter under consideration. It was Rs 1,112.92 crore for the same period a year ago
Fortis Healthcare Ltd.    
29 May 2021
233.95
-1.74%
Fortis Healthcare Ltd.    
29 May 2021
233.95
-1.74%
Fortis Healthcare Ltd - 532843 - Outcome Of The Board Meeting
BSE India
Dear Sir(s), Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today inter-alia, considered and approved the Audited Standalone and Consolidated Financial results of the Company for the quarter and financial year ended March 31, 2021. M/s B S R and Co. LLP, the Statutory Auditors of the Company have issued an Audit Report with modified opinion along with Statement of impact of Modified Opinion thereon; Accordingly, please find enclosed Audited standalone and consolidated financial results along with audit report along with Statement of impact of Modified Opinion given by the Statutory Auditor of the Company for year ended March 31, 2021. Further, a copy of the press release and investor presentation being issued in this regard is also enclosed. The meeting commenced at 12 Noon and concluded at 18:10 Hours IST. T
Fortis Healthcare Ltd.    
26 May 2021
233.95
-1.74%
Fortis Malar Standalone March 2021 Net Sales at Rs 19.83 crore, down 10.49% Y-o-Y
Fortis Healthcare Ltd. has gained 47.84% in the last 6 Months
Fortis Healthcare Ltd.    
25 May 2021
233.95
-1.74%
Fortis Hospitals rolls out vaccination camps in RWAs, companies in Bengaluru
Fortis Healthcare Ltd. is trading above all available SMAs
Fortis Healthcare Ltd.    
22 May 2021
233.95
-1.74%
In-Depth | Everything you need to know about COVID-19 therapeutics in India
In-Depth | Everything you need to know about COVID-19 therapeutics in India
Moneycontrol
Several drugs are being used to treat COVID-19 patients. Moneycontrol looks at their efficacy and risks, as explained by Dr Rahul Pandit, director of critical care at Fortis Hospital Mumbai and member of Maharashtra's COVID task force.
Fortis Healthcare Ltd. has gained 26.70% in the last 3 Months
Fortis Healthcare Ltd.    
22 May 2021
233.95
-1.74%
Fortis Healthcare Ltd - 532843 - Board Meeting Intimation for Notice Of Board Meeting Under Regulation ...
BSE India
FORTIS HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Saturday, May 29, 2021 to, inter-alia, consider and approve audited financial results for the year ended March 31, 2021. Further, in continuation to our letter ref. FHL/SEC/2020-21 dated March 31, 2021 captioned 'Closure of Trading Window', it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till May 31, 2021. This is for your information and record please.
Total Votes: 204
BUY
SELL
HOLD
76.47%
12.75%
10.78%